i det mindste ser det ud til at arzerra+alkylator slår ibrutinib som monoterapi - http://www.prnewswire.com/news-releases/ibrutinib-data-published-in-the-lancet-oncology-suggest-a-positive-effect-in-previously-untreated-chronic-lymphocytic-leukemia-patients-over-age-65-235149691.html

]]>https://dev.proinvestor.com/forum/topic/449987/i-det-mindste-ser-det-ud-til-at-arzerraalkylator-slr-ibrutinib-som-monoterapi-httpwwwprnewswirecomnews-releasesibrutinib-data-published-in-the-lancet-oncology-suggest-a-positive-effect-in-pRSS for NodeSat, 13 Jun 2026 18:20:21 GMTThu, 23 Feb 2017 12:09:00 GMT60